BIO-Europe 2017 is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high profile exhibition, and private, prescheduled one-to-one meetings. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships. The BIO-Europe 2017 partnering event is expected to draw over 3,800 industry attendees for three days of high level networking, representing upwards of 2,000 companies from over 60 countries. We believe that Cromos™ Pharma’s expertise in clinical trials in Eastern Europe and ex-USSR countries (Belarus, Georgia, Moldova, Russia, Ukraine) will add value to the drug development programs of most participants.
Cromos Pharma is delighted to be participating in MAGI’s Clinical Research vConference (2-5 & 9-12 November). Our CEO Vlad Bogin, MD, FACP will be giving a presentation on the timely topic of Crisis Management (2 November, 2:30 PM-3:30 PM).